SCHEMBL6316498

SCHEMBL6316498

CCCCNC(=O)c1c(-c2ccccn2)noc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.43
EDNRB P24530 3/20 0.41
EDNRA P25101 3/20 0.41
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
P4HTM Q9NXG6 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
GHSR Q92847 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
TSHR P16473 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NAAA Q02083 1/20 0.39
KAT6A Q92794 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6324666 0.90 GAA (0.42) GAAEDNRAHTTSMN1; SMN2ALDH1A1
SCHEMBL6315769 0.88 L3MBTL1 (0.42) GAAHTTSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL6316355 0.86 KDM4E (0.44) GAAEDNRAHTTSMN1; SMN2ALDH1A1
SCHEMBL6315466 0.86 NAAA (0.47) GAAHTTSMN1; SMN2ALDH1A1MAPT
SCHEMBL6323422 0.84 HTT (0.46) GAAHTTSMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL6322628 0.83 HTT (0.45) GAAHTTSMN1; SMN2TSHR
SCHEMBL6318626 0.82 SMN1; SMN2 (0.47) GAAHTTSMN1; SMN2ALDH1A1MAPT
SCHEMBL6316902 0.82 MAPK14 (0.45) GAAHTTSMN1; SMN2L3MBTL1MEN1
SCHEMBL6318154 0.82 GAA (0.46) GAAEDNRBEDNRAHTTALDH1A1
SCHEMBL6324589 0.82 EDNRA (0.48) EDNRBEDNRAP4HTMKAT6A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US claimed
EP-1435948-A1 AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-07-14 EP claimed
WO-2003013517-A1 AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS PHARMACIA ITALIA S.P.A. (IT) 2003-02-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 GAA 789/4885EDNRB 4597/4885EDNRA 4545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.